Skip to main content

David Alland

NIH Rank #310
  • Top 5% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1941013Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$11.9M
Full award amounts, FY2025
Award Records
14
Records listing this PI
Award-Linked Rank
#310
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for David Alland. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing David Alland as a PI. Multi-PI records show the full award amount for context.

  • 1R01AI190528-01R01
    FEND-TB
    $2.6M
    award amount
  • 5R01AI147345-05R01
    Bacteria and Host in TB Transmission
    $1.6M
    award amount
  • 5UC7AI180307-03UC7
    Resources, Workforce Development, and Animal Models for the Rutgers RBL
    $1.5M
    award amount
  • 1R01AI194375-01R01
    Transmission Links and Clinical Spectrum of Exhaled Mycobacterium Tuberculosis
    $1M
    award amount
  • 1U19AI189168-01U19
    Center for accelerated development of drug candidates targeting high threat bacterial infections
    $944.1K
    award amount
  • 1R01AI189899-01R01
    Unraveling the spectrum of intrabacterial amide hydrolysis to develop new classes of pyrazinoic acid prodrugs against pyrazinamide resistant Mycobacterium tuberculosis
    $813.4K
    award amount
  • 1U19AI189183-01U19
    Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
    $778.5K
    award amount
  • 5R01AI182257-02R01
    Point of care detection of fluroquinolone, bedaquiline and linezolid resistant Mycobacterium tuberculosis for rapid treatment decisions.
    $759K
    award amount
  • 5R01AI179961-02R01
    Nanoreactor beads for POC TB resistance testing
    $687K
    award amount
  • 5U19AI162598-05U19
    Bacterial and Host Heterogeneity in TB latency, persistence and progression
    $602.9K
    award amount

+4 more grants not shown.

Award organizations

Organizations that administered FY2025 awards listing David Alland as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Rutgers University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #330
  8. 2024
    Entered Top 25% Nationally
    Ranked #330
  9. 2024
    Entered Top 10% Nationally
    Ranked #330
  10. 2024
    Entered Top 5% Nationally
    Ranked #330
  11. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  12. 2025
    R01 Grant Holder
  13. 2026
    $25M Cumulative Funding